Literature DB >> 19946510

Radiation recall dermatitis with soft tissue necrosis following pemetrexed therapy: a case report.

Christian Spirig1, Aurelius Omlin, Giannicola D'Addario, Klaus-Dieter Loske, Philipp Esenwein, Jan Henning Geismar, Thomas Ruhstaller.   

Abstract

INTRODUCTION: Radiation recall dermatitis is a well known but still poorly understood inflammatory reaction. It can develop in previously irradiated areas and has been shown to be triggered by a variety of different drugs, including cytostatic agents. Pemetrexed may cause radiation recall dermatitis in pre-irradiated patients. CASE
PRESENTATION: We present the case of a 49-year-old Caucasian woman with non-small cell lung cancer who was initially treated with carboplatin and paclitaxel concomitant with radiotherapy after suffering a painful plexus brachialis infiltration. Due to disease progression, a second-line treatment with pemetrexed was started. A severe soft tissue necrosis developed despite steroid treatment and plastic surgery.
CONCLUSION: To the best of our knowledge, we present the first case of a patient with severe soft tissue necrosis in a pre-irradiated area after pemetrexed therapy. We believe that physicians treating patients with pemetrexed should be aware of the severe, possibly life-threatening effects that may be induced by pemetrexed after previous radiation therapy.

Entities:  

Year:  2009        PMID: 19946510      PMCID: PMC2783093          DOI: 10.1186/1752-1947-3-93

Source DB:  PubMed          Journal:  J Med Case Rep        ISSN: 1752-1947


  9 in total

1.  Side effects of chemotherapy. Case 1. Radiation recall dermatitis from gemcitabine.

Authors:  H J Burstein
Journal:  J Clin Oncol       Date:  2000-02       Impact factor: 44.544

2.  Potentiation of x-ray effects by actinomycin D.

Authors:  G J D'ANGIO; S FARBER; C L MADDOCK
Journal:  Radiology       Date:  1959-08       Impact factor: 11.105

3.  Radiation recall dermatitis with pemetrexed.

Authors:  J Hureaux; Y Le Guen; C Tuchais; L Savary; T Urban
Journal:  Lung Cancer       Date:  2005-08-18       Impact factor: 5.705

4.  Unsuccessful rechallenge with pemetrexed after a previous radiation recall dermatitis.

Authors:  Fabrice Barlési; Céline Tummino; Anne-Marie Tasei; Philippe Astoul
Journal:  Lung Cancer       Date:  2006-10-17       Impact factor: 5.705

5.  Radiation recall dermatitis and pneumonitis in a patient treated with paclitaxel.

Authors:  V G Schweitzer; G J Juillard; C L Bajada; R G Parker
Journal:  Cancer       Date:  1995-09-15       Impact factor: 6.860

6.  Letter: Adriamycin activating a recall phenomenon after radiation therapy.

Authors:  S S Donaldson; J M Glick; J R Wilbur
Journal:  Ann Intern Med       Date:  1974-09       Impact factor: 25.391

7.  Taxol and radiation recall dermatitis.

Authors:  V T Raghavan; W D Bloomer; D E Merkel
Journal:  Lancet       Date:  1993-05-22       Impact factor: 79.321

8.  Gemcitabine-related radiation recall in a patient with pancreatic cancer.

Authors:  M Wasif Saif; Sandra Sellers; Suzanne Russo
Journal:  Anticancer Drugs       Date:  2006-01       Impact factor: 2.248

Review 9.  Gemcitabine-induced radiation recall.

Authors:  Melenda D Jeter; Pasi A Jänne; Sarah Brooks; Harold J Burstein; Patrick Wen; Charles S Fuchs; Jay S Loeffler; Phillip M Devlin; Ravi Salgia
Journal:  Int J Radiat Oncol Biol Phys       Date:  2002-06-01       Impact factor: 7.038

  9 in total
  6 in total

1.  Pemetrexed-induced radiation recall dermatitis in a patient with lung adenocarcinoma: case report and literature review.

Authors:  Jin Ge; Vivek Verma; Andrew Hollander; Corey Langer; Charles B Simone
Journal:  J Thorac Dis       Date:  2016-12       Impact factor: 2.895

2.  Revisiting cutaneous adverse reactions to pemetrexed.

Authors:  Claudine Piérard-Franchimont; Pascale Quatresooz; Marie-Annick Reginster; Gérald E Piérard
Journal:  Oncol Lett       Date:  2011-07-05       Impact factor: 2.967

3.  Harmless effects of argon plasma on caudal fin regeneration and embryogenesis of zebrafish: novel biological approaches for safe medical applications of bioplasma.

Authors:  Min-Kyung Nam; Goo-Young Kim; Si-Eun Yun; Ja-Young Jang; Yong-Hee Kim; Eun Ha Choi; Seongman Kang; Hyangshuk Rhim
Journal:  Exp Mol Med       Date:  2017-07-14       Impact factor: 8.718

4.  Sociodemographic, clinical profile, and treatment characteristics of oncology patients developing radiation recall phenomenon: Two tertiary care center's experience of an eternal unpredictable phenomenon of cancer treatment.

Authors:  Abhishek Purkayastha; Neelam Sharma; Sachin Taneja; Virender Suhag; Nishant Lohia
Journal:  Tzu Chi Med J       Date:  2021-12-10

5.  Radiation Recall Dermatitis After the Use of Pralatrexate for Peripheral T-cell Lymphoma.

Authors:  Ronik S Bhangoo; Munveer S Bhangoo; Aaron R Mangold; William W Wong
Journal:  Adv Radiat Oncol       Date:  2018-10-12

Review 6.  Epidemiology of infections in cancer patients.

Authors:  Teresa R Zembower
Journal:  Cancer Treat Res       Date:  2014
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.